Article Name Medical Diagnostic

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Olympus Strengthens its Medical Portfolio with Successful Acquisition of Taewoong Medical Co., Ltd, a Leading Korean Gastrointestinal Stent Company...Read more

24th January, 2024 | By Vrushti Kothari 


Veeva Pulse Shows Doctors Opening Up Two-Way Communications Doubles Digital Engagement

Digital channels are emerging as the preferred method for engagement with field teams in Asia...Read more

24th January, 2024 | By Vrushti Kothari 


Fujirebio and Agappe Forge Strategic Partnership in CLIA-Based Immunoassay Solutions

In a groundbreaking initiative, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd have joined forces in a Contract Development and Manufacturing Organization (CDMO) collaboration focused on advancing Cartridge-based CL...Read more

20th January, 2024


Qure.ai and Project Data Sphere partner to focus on advancing cancer research using AI

Addressing the critical need for automating and standardising tumour response assessments in medical imaging...Read more

19th January, 2024 | By Vrushti Kothari 


Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung's premium X-ray devices...Read more

17th January, 2024 | By Vrushti Kothari 


Apollo Hospital Seshadripuram Partners with LifeSigns, inducts advanced AI-Powered 24x7 Remote Patient Monitoring System

Hospital to monitor all patients digitally with the use of technology and biosensors...Read more

11th January, 2024 | By Vrushti Kothari 


“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a diseas...Read more

08th January, 2024


Targeted Battle Against HPV

Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations...Read more

08th January, 2024


Varian & Nova Scotia Health Forge Groundbreaking Oncology Partnership for Cancer Care Advancements

Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health...Read more

05th January, 2024


Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity

Clinical Advancements in Obesity Treatment: Innovent Biologics Initiates Phase 3 Trial of Mazdutide...Read more

02nd January, 2024 | By Vrushti Kothari 


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer